Concepedia

Louise Goodwin

LG

Statistics

Publications

17

Citations

2.2K

H-Index

15

Active since

1997

Affiliations

AstraZeneca (United Kingdom)(Current)

University of Sheffield

Royal Hallamshire Hospital

John Radcliffe Hospital

University of Cambridge

Louise Goodwin is an author at AstraZeneca (United Kingdom) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1997–2023

17

Publications

17

Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress

Zachary T. Schug, Barrie Peck, Dylan T. Jones et al. · Cancer Cell · 2015 · 796 citations · Full text

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study

Derek J. Rosario, J. Athene Lane, Chris Metcalfe et al. · BMJ · 2012 · 275 citations · Full text

Design and Synthesis of Novel Lactate Dehydrogenase A Inhibitors by Fragment-Based Lead Generation

Richard A. Ward, C. Brassington, Alexander L. Breeze et al. · Journal of Medicinal Chemistry · 2012 · 169 citations · Full text

, , +19

Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically

Lucy C. Riches, Antonio G. Trinidad, Gareth Hughes et al. · Molecular Cancer Therapeutics · 2019 · 155 citations · Full text

Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received

David E. Neal, Chris Metcalfe, Jenny Donovan et al. · European Urology · 2019 · 147 citations · Full text

1–5 of 17